Document is current
Any future updates will be listed below
-
Authors
Valentin-Alvarado, Luis E. http://orcid.org/0000-0001-7988-8556
Appler, Kathryn E. http://orcid.org/0000-0002-1219-1786
De Anda, Valerie
Schoelmerich, Marie C.
West-Roberts, Jacob
Kivenson, Veronika
Crits-Christoph, Alexander
Ly, Lynn http://orcid.org/0000-0001-6321-8996
Sachdeva, Rohan http://orcid.org/0000-0001-9284-2245
Greening, Chris http://orcid.org/0000-0001-7616-0594
Savage, David F. http://orcid.org/0000-0003-0042-2257
Baker, Brett J. http://orcid.org/0000-0002-5971-1021
Banfield, Jillian F. http://orcid.org/0000-0001-8203-8771
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-037174)
Simons Foundation (LI-SIAME-00002001)
- License Information
-
More Information
Article History
Received: 2 May 2024
Accepted: 20 June 2024
First Online: 31 July 2024
Competing interests
: J.F.B. is a co-founder of Metagenomi. D.F.S. is a co-founder and scientific advisory board member of Scribe Therapeutics. L.L. is an employee of Oxford Nanopore Technologies, Inc., and is a stock or stock option holder of Oxford Nanopore Technologies plc. The other authors declare that they have no competing interests.
